LIST OF TABLES

TABLE 01. GLOBAL CANCER PAIN MARKET, BY DRUG TYPE, 20172025 ($MILLION)
TABLE 02. OPIOIDS MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 03. OPIOIDS MARKET, BY REGION, 20172025 ($MILLION)
TABLE 04. NON-OPIOIDS MARKET, BY TYPE, 20172025 ($MILLION)
TABLE 05. NON-OPIOIDS MARKET, BY REGION, 20172025 ($MILLION)
TABLE 06. NERVE BLOCKERS MARKET, BY REGION, 20172025 ($MILLION)
TABLE 07. GLOBAL CANCER PAIN MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 08. LUNG CANCER PAIN MARKET, BY REGION, 20172025 ($MILLION)
TABLE 09. COLORECTAL CANCER PAIN MARKET, BY REGION, 20172025 ($MILLION)
TABLE 10. BREAST CANCER PAIN MARKET, BY REGION, 20172025 ($MILLION)
TABLE 11. PROSTATE CANCER PAIN MARKET, BY REGION, 20172025 ($MILLION)
TABLE 12. BLOOD CANCER PAIN MARKET, BY REGION, 20172025 ($MILLION)
TABLE 13. CANCER PAIN MARKET FOR OTHER DISEASE INDICATION, BY REGION, 20172025 ($MILLION)
TABLE 14. CANCER PAIN MARKET REVENUE, BY REGION, 20172025 ($MILLION)
TABLE 15. NORTH AMERICA CANCER PAIN MARKET REVENUE, BY COUNTRY, 20172025 ($MILLION)
TABLE 16. U.S. CANCER PAIN MARKET, BY TYPE, 20162023 ($MILLION)
TABLE 17. U.S. CANCER PAIN MARKET, BY DISEASE INDICATION, 20162023 ($MILLION)
TABLE 18. CANADA CANCER PAIN MARKET, BY TYPE, 20162023 ($MILLION)
TABLE 19. CANADA CANCER PAIN MARKET, BY DISEASE INDICATION, 20162023 ($MILLION)
TABLE 20. MEXICO CANCER PAIN MARKET, BY TYPE, 20162023 ($MILLION)
TABLE 21. MEXICO CANCER PAIN MARKET, BY DISEASE INDICATION, 20162023 ($MILLION)
TABLE 22. NORTH AMERICA CANCER PAIN MARKET REVENUE, BY TYPE, 20172025 ($MILLION)
TABLE 23. NORTH AMERICA CANCER PAIN MARKET REVENUE, BY DISEASE INDICATION, 20172025 ($MILLION)
TABLE 24. EUROPE CANCER PAIN MARKET REVENUE, BY COUNTRY, 20172025 ($MILLION)
TABLE 25. GERMANY CANCER PAIN MARKET, BY TYPE, 20162023 ($MILLION)
TABLE 26. GERMANY CANCER PAIN MARKET, BY DISEASE INDICATION, 20162023 ($MILLION)
TABLE 27. FRANCE CANCER PAIN MARKET, BY TYPE, 20162023 ($MILLION)
TABLE 28. FRANCE CANCER PAIN MARKET, BY DISEASE INDICATION, 20162023 ($MILLION)
TABLE 29. UK CANCER PAIN MARKET, BY TYPE, 20162023 ($MILLION)
TABLE 30. UK CANCER PAIN MARKET, BY DISEASE INDICATION, 20162023 ($MILLION)
TABLE 31. ITALY CANCER PAIN MARKET, BY TYPE, 20162023 ($MILLION)
TABLE 32. ITALY CANCER PAIN MARKET, BY DISEASE INDICATION, 20162023 ($MILLION)
TABLE 33. SPAIN CANCER PAIN MARKET, BY TYPE, 20162023 ($MILLION)
TABLE 34. SPAIN CANCER PAIN MARKET, BY DISEASE INDICATION, 20162023 ($MILLION)
TABLE 35. REST OF EUROPE CANCER PAIN MARKET, BY TYPE, 20162023 ($MILLION)
TABLE 36. REST OF EUROPE CANCER PAIN MARKET, BY DISEASE INDICATION, 20162023 ($MILLION)
TABLE 37. EUROPE CANCER PAIN MARKET REVENUE, BY TYPE, 20172025 ($MILLION)
TABLE 38. EUROPE CANCER PAIN MARKET REVENUE, BY DISEASE INDICATION, 20172025 ($MILLION)
TABLE 39. ASIA-PACIFIC CANCER PAIN MARKET REVENUE, BY COUNTRY, 20172025 ($MILLION)
TABLE 40. JAPAN CANCER PAIN MARKET, BY TYPE, 20162023 ($MILLION)
TABLE 41. JAPAN CANCER PAIN MARKET, BY DISEASE INDICATION, 20162023 ($MILLION)
TABLE 42. CHINA CANCER PAIN MARKET, BY TYPE, 20162023 ($MILLION)
TABLE 43. CHINA CANCER PAIN MARKET, BY DISEASE INDICATION, 20162023 ($MILLION)
TABLE 44. AUSTRALIA CANCER PAIN MARKET, BY TYPE, 20162023 ($MILLION)
TABLE 45. AUSTRALIA CANCER PAIN MARKET, BY DISEASE INDICATION, 20162023 ($MILLION)
TABLE 46. INDIA CANCER PAIN MARKET, BY TYPE, 20162023 ($MILLION)
TABLE 47. INDIA CANCER PAIN MARKET, BY DISEASE INDICATION, 20162023 ($MILLION)
TABLE 48. REST OF ASIA- PACIFIC CANCER PAIN MARKET, BY TYPE, 20162023 ($MILLION)
TABLE 49. REST OF ASIA- PACIFIC CANCER PAIN MARKET, BY DISEASE INDICATION, 20162023 ($MILLION)
TABLE 50. ASIA-PACIFIC CANCER PAIN MARKET REVENUE, BY TYPE, 20172025 ($MILLION)
TABLE 51. ASIA-PACIFIC CANCER PAIN MARKET REVENUE, BY DISEASE INDICATION, 20172025 ($MILLION)
TABLE 52. LAMEA CANCER PAIN MARKET REVENUE, BY COUNTRY, 20172025 ($MILLION)
TABLE 53. BRAZIL CANCER PAIN MARKET, BY TYPE, 20162023 ($MILLION)
TABLE 54. BRAZIL CANCER PAIN MARKET, BY DISEASE INDICATION, 20162023 ($MILLION)
TABLE 55. SAUDI ARABIA CANCER PAIN MARKET, BY TYPE, 20162023 ($MILLION)
TABLE 56. SAUDI ARABIA CANCER PAIN MARKET, BY DISEASE INDICATION, 20162023 ($MILLION)
TABLE 57. SOUTH AFRICA CANCER PAIN MARKET, BY TYPE, 20162023 ($MILLION)
TABLE 58. SOUTH AFRICA CANCER PAIN MARKET, BY DISEASE INDICATION, 20162023 ($MILLION)
TABLE 59. REST OF LAMEA CANCER PAIN MARKET, BY TYPE, 20162023 ($MILLION)
TABLE 60. REST OF LAMEA CANCER PAIN MARKET, BY DISEASE INDICATION, 20162023 ($MILLION)
TABLE 61. LAMEA CANCER PAIN MARKET REVENUE, BY TYPE, 20172025 ($MILLION)
TABLE 62. LAMEA CANCER PAIN MARKET VOLUME, BY DISEASE INDICATION, 20172025 (UNITS)
TABLE 63. AOXING PHARM: COMPANY SNAPSHOT
TABLE 64. AOXING PHARM: OPERATING SEGMENTS
TABLE 65. AOXING PHARM: PRODUCT PORTFOLIO
TABLE 66. BDSI: COMPANY SNAPSHOT
TABLE 67. BDSI: OPERATING SEGMENTS
TABLE 68. BDSI: PRODUCT PORTFOLIO
TABLE 69. DAIICHI SANKYO: COMPANY SNAPSHOT
TABLE 70. DAIICHI SANKYO: PRODUCT PORTFOLIO
TABLE 71. GRNENTHAL: COMPANY SNAPSHOT
TABLE 72. GRNENTHAL: PRODUCT PORTFOLIO
TABLE 73. HISAMITSU PHARMACEUTICAL: COMPANY SNAPSHOT
TABLE 74. HISAMITSU PHARMACEUTICAL: OPERATING SEGMENTS
TABLE 75. HISAMITSU PHARMACEUTICAL: PRODUCT PORTFOLIO
TABLE 76. INSYS: COMPANY SNAPSHOT
TABLE 77. INSYS: OPERATING SEGMENTS
TABLE 78. INSYS: PRODUCT PORTFOLIO
TABLE 79. MUNDIPHARMA: COMPANY SNAPSHOT
TABLE 80. MUNDIPHARMA: PRODUCT PORTFOLIO
TABLE 81. OREXO: COMPANY SNAPSHOT
TABLE 82. OREXO: OPERATING SEGMENTS
TABLE 83. OREXO: PRODUCT PORTFOLIO
TABLE 84. PFIZER: COMPANY SNAPSHOT
TABLE 85. PFIZER: OPERATING SEGMENTS
TABLE 86. PFIZER: PRODUCT PORTFOLIO
TABLE 87. TEVA: COMPANY SNAPSHOT
TABLE 88. TEVA: OPERATING SEGMENTS
TABLE 89. TEVA: PRODUCT PORTFOLIO

LIST OF FIGURE

LIST OF FIGURES

FIGURE 01. GLOBAL CANCER PAIN MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP PLAYER POSITIONING, 2017
FIGURE 04. WORLD POPULATION AGED 65 AND OVER (%)
FIGURE 05. IMPACT ANALYSES
FIGURE 06. MORPHINE MARKET FOR CANCER PAIN, 20172025 ($MILLION)
FIGURE 07. FENTANYL MARKET FOR CANCER PAIN, 20172025 ($MILLION)
FIGURE 08. OTHERS MARKET FOR CANCER PAIN, 20172025 ($MILLION)
FIGURE 09. COMPARATIVE ANALYSIS OF OPIOIDS MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 10. ACETAMINOPHEN MARKET FOR CANCER PAIN, 20172025 ($MILLION)
FIGURE 11. NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) MARKET FOR CANCER PAIN, 20172025 ($MILLION)
FIGURE 12. COMPARATIVE ANALYSIS OF NON-OPIOIDS, MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 13. COMPARATIVE ANALYSIS OF NERVE BLOCKERS MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 14. COMPARATIVE ANALYSIS OF LUNG CANCER PAIN MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 15. COMPARATIVE ANALYSIS OF COLORECTAL CANCER PAIN MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 16. COMPARATIVE ANALYSIS OF BREAST CANCER PAIN MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 17. COMPARATIVE ANALYSIS OF PROSTATE CANCER PAIN MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 18. COMPARATIVE ANALYSIS OF BLOOD CANCER PAIN MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 19. COMPARATIVE ANALYSIS OF CANCER PAIN MARKET FOR OTHER INDICATION MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 20. AOXING PHARM: REVENUE, 20152017 ($MILLION)
FIGURE 21. BDSI: NET SALES, 20152017 ($MILLION)
FIGURE 22. DAIICHI SANKYO: NET SALES, 20152017 ($MILLION)
FIGURE 23. HISAMITSU PHARMACEUTICAL REVENUE, 20152017 ($MILLION)
FIGURE 24. HISAMITSU PHARMACEUTICAL: REVENUE SHARE BY BUSINESS SEGMENT, 2017 (%)
FIGURE 25. HISAMITSU PHARMACEUTICAL: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 26. INSYS: NET SALES, 20152017 ($MILLION)
FIGURE 27. OREXO: REVENUE, 20152017 ($MILLION)
FIGURE 28. OREXO: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 29. PFIZER: REVENUE, 20152017 ($MILLION)
FIGURE 30. PFIZER: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 31. PFIZER: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 32. TEVA: REVENUE, 20152017 ($MILLION)
FIGURE 33. TEVA: REVENUE BY SEGMENT, 2017 (%)
FIGURE 34. TEVA: REVENUE SHARE BY REGION, 2017 (%)